Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials.

Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, Derks E, Leufkens H, Denys D.

Eur Neuropsychopharmacol. 2017 Jan;27(1):82-86. doi: 10.1016/j.euroneuro.2016.10.004. Epub 2016 Nov 11.

PMID:
27842941
2.

Psychopathological characteristics of patients with first-episode psychosis and chronic schizophrenia: a descriptive comparison.

Del Bello V, Menculini G, Moretti P, Tortorella A.

Psychiatr Danub. 2016 Sep;28(Suppl-1):39-44.

PMID:
27663803
3.

[The Relationship between Violence and Clinical Features, Insight and Cognitive Functions in Patients with Schizophrenia].

Köşger F, Eşsizoğlu A, Sönmez İ, Güleç G, Genek M, Akarsu Ö.

Turk Psikiyatri Derg. 2016 Summer;27(2):0. Turkish.

4.

Associations with violent and homicidal behaviour among men with schizophrenia.

Karabekiroğlu A, Pazvantoğlu O, Karabekiroğlu K, Böke Ö, Korkmaz IZ.

Nord J Psychiatry. 2016;70(4):303-8. doi: 10.3109/08039488.2015.1109139. Epub 2015 Dec 4.

PMID:
26634311
5.

Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).

Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A.

Eur Neuropsychopharmacol. 2015 Jun;25(6):808-16. doi: 10.1016/j.euroneuro.2015.02.012. Epub 2015 Apr 20.

PMID:
25907250
6.

Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia.

Fervaha G, Agid O, Takeuchi H, Lee J, Foussias G, Remington G.

J Clin Psychopharmacol. 2015 Apr;35(2):128-33. doi: 10.1097/JCP.0000000000000286.

PMID:
25679125
7.

Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?

Anderson A, Wilcox M, Savitz A, Chung H, Li Q, Salvadore G, Wang D, Nuamah I, Riese SP, Bilder RM.

Psychiatry Res. 2015 Feb 28;225(3):283-90. doi: 10.1016/j.psychres.2014.12.025. Epub 2015 Jan 6.

8.

Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning.

Zhou Y, Rosenheck R, Mohamed S, Zhang J, Chang Q, Ou Y, Sun B, Ning Y, He H.

Schizophr Res. 2015 Feb;161(2-3):376-81. doi: 10.1016/j.schres.2014.12.009. Epub 2014 Dec 19.

PMID:
25533592
9.

[Insight and social functioning in deficit and nondeficit schizophrenia].

Köşger F, Şahin H, Eşsizoğlu A, Aksaray G.

Turk Psikiyatri Derg. 2014 Fall;25(3):157-62. Turkish.

10.

Influence of psycho-social factors on the emergence of depression and suicidal risk in patients with schizophrenia.

Pješčić KD, Nenadović MM, Jašović-Gašić M, Trajković G, Kostić M, Ristić-Dimitrijević R.

Psychiatr Danub. 2014 Sep;26(3):226-30.

11.

Metacognitive training for schizophrenia: a multicentre randomised controlled trial.

Briki M, Monnin J, Haffen E, Sechter D, Favrod J, Netillard C, Cheraitia E, Marin K, Govyadovskaya S, Tio G, Bonin B, Chauvet-Gelinier JC, Leclerc S, Hodé Y, Vidailhet P, Berna F, Bertschy AZ, Vandel P.

Schizophr Res. 2014 Aug;157(1-3):99-106. doi: 10.1016/j.schres.2014.06.005. Epub 2014 Jun 24.

PMID:
24972754
12.

Translation into Arabic and validation of the Schedule for the Assessment of Insight-Expanded Version (SAI-E) for use in Tunisia.

Nakhli J, Mlika S, Bouhlel S, Amamou B, Chaieb I, Ben Nasr S, Ben Hadj Ali B.

Compr Psychiatry. 2014 May;55(4):1050-4. doi: 10.1016/j.comppsych.2014.02.016. Epub 2014 Mar 4.

PMID:
24636191
13.

Insight, neurocognition, and schizophrenia: predictive value of the wisconsin card sorting test.

Stratton J, Yanos PT, Lysaker P.

Schizophr Res Treatment. 2013;2013:696125. doi: 10.1155/2013/696125. Epub 2013 Nov 4.

14.

Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia.

Michel P, Baumstarck K, Auquier P, Amador X, Dumas R, Fernandez J, Lancon C, Boyer L.

BMC Psychiatry. 2013 Sep 22;13:229. doi: 10.1186/1471-244X-13-229.

15.

The denial of aggression in violent patients with schizophrenia.

Krakowski MI, Czobor P.

Schizophr Res. 2012 Nov;141(2-3):228-33. doi: 10.1016/j.schres.2012.08.037. Epub 2012 Sep 23.

PMID:
23010487
16.

Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.

Aggarwal NK, Zhang XY, Stefanovics E, Chen DC, Xiu MH, Xu K, Rosenheck RA.

J Nerv Ment Dis. 2012 Sep;200(9):814-20. doi: 10.1097/NMD.0b013e318266bcaa.

17.

Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.

Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.

Eur Psychiatry. 2012 Nov;27(8):625-33. doi: 10.1016/j.eurpsy.2012.01.001. Epub 2012 Apr 28.

PMID:
22542652
18.

Clinical and cognitive correlates of insight in first-episode schizophrenia.

Chan SK, Chan KK, Lam MM, Chiu CP, Hui CL, Wong GH, Chang WC, Chen EY.

Schizophr Res. 2012 Mar;135(1-3):40-5. doi: 10.1016/j.schres.2011.12.013. Epub 2012 Jan 13.

PMID:
22245186
19.

Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation.

Aggarwal NK, Tao H, Xu K, Stefanovics E, Zhening L, Rosenheck RA.

Schizophr Res. 2011 Nov;132(2-3):146-52. doi: 10.1016/j.schres.2011.08.003. Epub 2011 Sep 1.

PMID:
21885258
20.

Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.

Levine SZ, Rabinowitz J, Rizopoulos D.

Psychiatry Res. 2011 Aug 15;188(3):446-52. doi: 10.1016/j.psychres.2011.03.014. Epub 2011 Apr 3.

PMID:
21463902

Supplemental Content

Loading ...
Support Center